Consistent with this assumption, it has been shown in murine models with resectable tumors that neoadjuvant T cell stimulation using antibodies targeting PD-1 and CD137 was more effective in preventing metastasis compared with the same treatment when applied after tumor resection (143). This evidence concerns the gene TNFRSF9 and neoplasm.